Background: Preservation of organ function and viability is a crucial factor for survival in cardiogenic shock (CS) patients. There is not information enough on cytoprotective substances that may delay organs damage in CS. We hypothesize that cytidine-5-diphosphocholine (CDP-choline) can act as a cytoprotective pharmacological measure that diminishes the target organ damage. So, we aimed to perform a review of works carried out in our institution to evaluate the effect of therapeutic cytoprotection of the CDP-choline. Summary: CDP-choline is an intermediate metabolite in the synthesis of phosphatidylcholine. It is also a useful drug for the treatment of acute ischaemic stroke, traumatic brain injury, and neurodegenerative diseases and has shown an excellent pharmacological safety profile as well. We review our institution’s work and described the cytoprotective effects of CDP-choline in experimental models of heart, liver, and kidney acute damage, where this compound was shown to diminish reperfusion-induced ventricular arrhythmias, oxidative stress, apoptotic cell death, inflammation, lactic acid levels and to preserve mitochondrial function. Key Messages: We propose that additional research is needed to evaluate the impact of cytoprotective therapy adjuvant to mitigate target organ damage in patients with CS.

1.
van Diepen
S
,
Katz
JN
,
Albert
NM
,
Henry
TD
,
Jacobs
AK
,
Kapur
NK
, et al,
American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary Management of Cardiogenic Shock
.
Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association
.
A Scientific Statement Am Heart Assoc
.
2017
;
136
(
16
):
e232
68
.
2.
Hochman
JS
,
Buller
CE
,
Sleeper
LA
,
Boland
J
,
Dzavik
V
,
Sanborn
TA
, et al
.
Cardiogenic shock complicating acute myocardial infarction: etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Ochoque cardiogénicoluded Coronaries for cardiogenic shocK
.
J Am Coll Cardiol
.
2000
;
36
(
3 Suppl A
):
1063
70
.
3.
Harjola
VP
,
Lassus
J
,
Sionis
A
,
Køber
L
,
Tarvasmäki
T
,
Spinar
J
, et al
.
Clinical picture and risk prediction of short-term mortality in cardiogenic shock
.
Eur J Heart Fail
.
2015
;
17
(
5
):
501
9
.
4.
Shah
M
,
Patnaik
S
,
Patel
B
,
Ram
P
,
Garg
L
,
Agarwal
M
, et al
.
Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States
.
Clin Res Cardiol
.
2018
;
107
(
4
):
287
303
.
5.
Chioncel
O
,
Parissis
J
,
Mebazaa
A
,
Thiele
H
,
Desch
S
,
Bauersachs
J
, et al
.
Epidemiology, pathophysiology and contemporary management of cardiogenic shock: a position statement from the Heart Failure Association of the European Society of Cardiology
.
Eur J Heart Fail
.
2020
;
22
(
8
):
1315
41
.
6.
Wijntjens
GW
,
Fengler
K
,
Fuernau
G
,
Jung
C
,
den Uil
C
,
Akin
S
, et al
.
Prognostic implications of microcirculatory perfusion versus macrocirculatory perfusion in cardiogenic shock: a CULPRIT-SHOCK substudy
.
Eur Heart J Acute Cardiovasc Care
.
2020
;
9
(
2
):
108
19
.
7.
De Backer
D
,
Creteur
J
,
Dubois
MJ
,
Sakr
Y
,
Vincent
JL
.
Microvascular alterations in patients with acute severe heart failure and cardiogenic shock
.
Am Heart J
.
2004
;
147
(
1
):
91
9
.
8.
den Uil
CA
,
Lagrand
WK
,
van der Ent
M
,
Jewbali
LS
,
Cheng
JM
,
Spronk
PE
, et al
.
Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock
.
Eur Heart J
.
2010
;
31
(
24
):
3032
9
.
9.
Merdji
H
,
Levy
B
,
Jung
C
,
Ince
C
,
Siegemund
M
,
Meziani
F
.
Microcirculatory dysfunction in cardiogenic shock
.
Ann Intensive Care
.
2023
;
13
(
1
):
38
.
10.
Skurk
C
,
Rottbauer
W
,
Kessler
M
,
Akin
I
,
Kluge
S
,
Burdelski
C
, et al
.
The ACCOST-HH trial
.
Eur Heart J
.
2020
;
41
(
45
):
4296
8
.
11.
Vincent
JL
,
Moreno
R
,
Takala
J
,
Willatts
S
,
De Mendonça
A
,
Bruining
H
, et al
.
The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine
.
Intensive Care Med
.
1996
;
22
(
7
):
707
10
.
12.
Vallabhajosyula
S
,
Dunlay
SM
,
Prasad
A
,
Kashani
K
,
Sakhuja
A
,
Gersh
BJ
, et al
.
Acute noncardiac organ failure in acute myocardial infarction with cardiogenic shock
.
J Am Coll Cardiol
.
2019
;
73
(
14
):
1781
91
.
13.
Kirschenbaum
LA
,
Astiz
ME
,
Rackow
EC
,
Saha
DC
,
Lin
R
.
Microvascular response in patients with cardiogenic shock
.
Crit Care Med
.
2000
;
28
(
5
):
1290
4
.
14.
Stenberg
TA
,
Kildal
AB
,
Sanden
E
,
How
OJ
,
Hagve
M
,
Ytrehus
K
, et al
.
The acute phase of experimental cardiogenic shock is counteracted by microcirculatory and mitochondrial adaptations
.
PLoS One
.
2014
;
9
(
9
):
e105213
.
15.
Fuernau
G
,
Poenisch
C
,
Eitel
I
,
Denks
D
,
de Waha
S
,
Pöss
J
, et al
.
Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial
.
Int J Cardiol
.
2015
;
191
:
159
66
.
16.
Tarvasmäki
T
,
Haapio
M
,
Mebazaa
A
,
Sionis
A
,
Silva-Cardoso
J
,
Tolppanen
H
, et al
.
Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality
.
Eur J Heart Fail
.
2018
;
20
(
3
):
572
81
.
17.
Shirakabe
A
,
Matsushita
M
,
Shibata
Y
,
Shighihara
S
,
Nishigoori
S
,
Sawatani
T
, et al
.
Organ dysfunction, injury, and failure in cardiogenic shock
.
J Intensive Care
.
2023
;
11
(
1
):
26
.
18.
Jantti
T
,
Tarvasmaki
T
,
Harjola
VP
,
Parissis
J
,
Pulkki
K
,
Sionis
A
, et al
.
Frequency and prognostic significance of abnormal liver function tests in patients with cardiogenic shock
.
Am J Cardiol
.
2017
;
120
(
7
):
1090
7
.
19.
Stegman
BM
,
Newby
LK
,
Hochman
JS
,
Ohman
EM
.
Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility
.
J Am Coll Cardiol
.
2012
;
59
(
7
):
644
7
.
20.
Thiele
H
,
Ohman
EM
,
de Waha-Thiele
S
,
Zeymer
U
,
Desch
S
.
Management of cardiogenic shock complicating myocardial infarction: an update 2019
.
Eur Heart J
.
2019
;
40
(
32
):
2671
83
.
21.
Gewartowska
M
,
Olszewski
WL
.
The new approaches to preservation of graft cell integrity in preservation for transplantation
.
Ann Transplant
.
2005
;
10
(
4
):
6
10
.
22.
Ughetto
A
,
Roubille
F
,
Molina
A
,
Battistella
P
,
Gaudard
P
,
Demaria
R
, et al
.
Heart graft preservation technics and limits: an update and perspectives
.
Front Cardiovasc Med
.
2023
;
10
:
1248606
.
23.
Li
N
,
Han
L
,
Wang
X
,
Qiao
O
,
Zhang
L
,
Gong
Y
.
Biotherapy of experimental acute kidney injury: emerging novel therapeutic strategies
.
Transl Res
.
2023
;
261
:
69
85
.
24.
Secades
JJ
,
Frontera
G
.
CDP-choline: pharmacological and clinical review
.
Methods Find Exp Clin Pharmacol
.
1995
;
17
(
Suppl B
):
1
54
.
25.
Secades
JJ
,
Gareri
P
.
Citicoline: pharmacological and clinical review, 2022 update
.
Rev Neurol
.
2022
;
75
(
s05
):
S1
89
.
26.
Secades
JJ
.
Role of citicoline in the management of traumatic brain injury
.
Pharmaceuticals
.
2021
;
14
(
5
):
410
.
27.
Schmidt
K
,
Hernekamp
JF
,
Doerr
M
,
Zivkovic
AR
,
Brenner
T
,
Walther
A
, et al
.
Cytidine-5-diphosphocholine reduces microvascular permeability during experimental endotoxemia
.
BMC Anesthesiol
.
2015
;
15
:
114
.
28.
González-Pacheco
H
,
Méndez-Domínguez
A
,
Hernández
S
,
López-Marure
R
,
Vazquez-Mellado
MJ
,
Aguilar
C
, et al
.
Pre-conditioning with CDP-choline attenuates oxidative stress-induced cardiac myocyte death in a hypoxia/reperfusion model
.
Sci World J
.
2014
;
2014
:
187071
.
29.
Hernández-Esquivel
L
,
Pavón
N
,
Buelna-Chontal
M
,
González-Pacheco
H
,
Belmont
J
,
Chávez
E
.
Citicoline (CDP-choline) protects myocardium from ischemia/reperfusion injury via inhibiting mitochondrial permeability transition
.
Life Sci
.
2014
;
96
(
1–2
):
53
8
.
30.
Hernández-Esquivel
L
,
Pavón
N
,
Buelna-Chontal
M
,
González-Pacheco
H
,
Belmont
J
,
Chávez
E
.
Cardioprotective properties of citicoline against hyperthyroidism-induced reperfusion damage in rat hearts
.
Biochem Cell Biol
.
2015
;
93
(
3
):
185
91
.
31.
Zazueta
C
,
Buelna-Chontal
M
,
Macías-López
A
,
Román-Anguiano
NG
,
González-Pacheco
H
,
Pavón
N
, et al
.
Cytidine-5'-Diphosphocholine protects the liver from ischemia/reperfusion injury preserving mitochondrial function and reducing oxidative stress
.
Liver Transpl
.
2018
;
24
(
8
):
1070
83
.
32.
Buelna-Chontal
M
,
Franco
M
,
Hernández-Esquivel
L
,
Pavón
N
,
Rodríguez-Zavala
JS
,
Correa
F
, et al
.
CDP-choline circumvents mercury-induced mitochondrial damage and renal dysfunction
.
Cell Biol Int
.
2017
;
41
(
12
):
1356
66
.
33.
Bloom
JE
,
Chan
W
,
Kaye
DM
,
Stub
D
.
State of shock: contemporary vasopressor and inotrope use in cardiogenic shock
.
J Am Heart Assoc
.
2023
;
12
(
15
):
e029787
.
You do not currently have access to this content.